Cargando…

Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo

BACKGROUND: The importance of the malignant cell environment to its growth and survival is becoming increasingly apparent, with dynamic cross talk between the neoplastic cell, the leukocyte infiltrate and the stroma. Most cancers are accompanied by leukocyte infiltration which, contrary to an antici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hannigan, Adele, Qureshi, Asif M, Nixon, Colin, Tsimbouri, Penelope M, Jones, Sarah, Philbey, Adrian W, Wilson, Joanna B
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041781/ https://www.ncbi.nlm.nih.gov/pubmed/21291541 http://dx.doi.org/10.1186/1476-4598-10-11

Ejemplares similares

Lymphoid Hyperplasia and Lymphoma in Transgenic Mice Expressing the Small Non-Coding RNA, EBER1 of Epstein-Barr Virus
por: Repellin, Claire E., et al.
Publicado: (2010)

Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2
por: AlQarni, Sana, et al.
Publicado: (2018)

Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition
por: Hannigan, Adele, et al.
Publicado: (2010)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

N-acetylcysteine (NAC) ameliorates Epstein-Barr virus latent membrane protein 1 induced chronic inflammation
por: Gao, Xiao, et al.
Publicado: (2017)

Immortalization of human lymphocytes by Epstein-Barr virus.
por: Miller, G.
Publicado: (1982)

Human Cd4(+) T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
por: Münz, Christian, et al.
Publicado: (2000)

Perspective: Contribution of Epstein–Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells
por: Wu, Chung-Chun, et al.
Publicado: (2018)

The Fight against the Carcinogenic Epstein-Barr Virus: Gut Microbiota, Natural Medicines, and Beyond
por: Eladwy, Radwa A., et al.
Publicado: (2023)

Expression of Epstein-Barr Virus Gene and Clonality of Infiltrated T Lymphocytes in Epstein-Barr Virus-associated Gastric Carcinoma
por: Lee, Jae Myun, et al.
Publicado: (2011)

Vaccination against Epstein–Barr Latent Membrane Protein 1 Protects against an Epstein–Barr Virus-Associated B Cell Model of Lymphoma
por: Soo Hoo, Wesley I., et al.
Publicado: (2023)

High Levels of Epstein-Barr Virus DNA in Latently Infected Gastric Adenocarcinoma
por: Ryan, Julie L., et al.
Publicado: (2008)

ZEB1 Regulates the Latent-Lytic Switch in Infection by Epstein-Barr Virus
por: Yu, Xianming, et al.
Publicado: (2007)

Contribution of Epstein–Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus
por: Kim, Kyoung-Dong, et al.
Publicado: (2020)

Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma
por: Salano, Valerie E., et al.
Publicado: (2021)

Characteristics of Epstein-Barr virus activation of human B lymphocytes
Publicado: (1981)

Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus(+) Hodgkin's Disease
por: Bollard, Catherine M., et al.
Publicado: (2004)

Epstein–Barr Virus-Specific Immune Control by Innate Lymphocytes
por: Münz, Christian
Publicado: (2017)

Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL)
por: Bahri, Racha, et al.
Publicado: (2022)

Epstein-Barr virus susceptibility of normal human B lymphocyte populations
Publicado: (1984)

The Synergistic Effect of Chemical Carcinogens Enhances Epstein-Barr Virus Reactivation and Tumor Progression of Nasopharyngeal Carcinoma Cells
por: Fang, Chih-Yeu, et al.
Publicado: (2012)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Epstein-Barr Virus Associated Modulation of Wnt Pathway Is Not Dependent on Latent Membrane Protein-1
por: Webb, Natasha, et al.
Publicado: (2008)

Modulation of the tumor microenvironment by Epstein‐Barr virus latent membrane protein 1 in nasopharyngeal carcinoma
por: Yoshizaki, Tomokazu, et al.
Publicado: (2018)

Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells
por: Xu, Jing-xiao, et al.
Publicado: (2023)

Identification of Epstein-Barr Virus in the Human Placenta and Its Pathologic Characteristics
por: Kim, Younghoon, et al.
Publicado: (2017)

Association of tumors having Epstein–Barr virus in surrounding lymphocytes with poor prognosis
por: Yogi, Norikazu, et al.
Publicado: (2022)

Cytolytic T lymphocytes from HLA-B8(+ )donors frequently recognize the Hodgkin's lymphoma associated latent membrane protein 2 of Epstein Barr virus
por: Tsang, Ming L, et al.
Publicado: (2011)

SURFACE MARKERS ON HUMAN B AND T LYMPHOCYTES : II. PRESENCE OF EPSTEIN-BARR VIRUS RECEPTORS ON B LYMPHOCYTES
por: Jondal, Mikael, et al.
Publicado: (1973)

GATA2 Deficiency and Epstein–Barr Virus Disease
por: Cohen, Jeffrey I.
Publicado: (2017)

Epstein-Barr Virus Limits the Accumulation of IPO7, an Essential Gene Product
por: Yang, Ya-Chun, et al.
Publicado: (2021)

Secretion of Epstein-Barr Virus-encoded BARF1 oncoprotein from latently infected B cells
por: Fiorini, Sylvie, et al.
Publicado: (2008)

Latent Epstein-Barr Virus Can Inhibit Apoptosis in B Cells by Blocking the Induction of NOXA Expression
por: Yee, Jade, et al.
Publicado: (2011)

Toll-Like Receptor 7 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1
por: Valente, Robert M., et al.
Publicado: (2012)

Defining the expression hierarchy of latent T-cell epitopes in Epstein-Barr virus infection with TCR-like antibodies
por: Sim, Adrian Chong Nyi, et al.
Publicado: (2013)

Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation
por: Caves, Elizabeth A., et al.
Publicado: (2017)

Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

Prognostic Role of the Expression of Latent-Membrane Protein 1 of Epstein–Barr Virus in Classical Hodgkin Lymphoma
por: Santisteban-Espejo, Antonio, et al.
Publicado: (2021)

Updates on Epstein–Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV
por: Ahmed, Naveed, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qlio7vbhjlbdrpom5hhkhu1upd